Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant bias » significant based (Expand Search), significant gap (Expand Search), significant degs (Expand Search)
decrease cgas » increased cgas (Expand Search), increases cgas (Expand Search)
bias decrease » sizes decrease (Expand Search), bias increases (Expand Search), a decrease (Expand Search)
Showing 161 - 180 results of 1,707 for search '(( significant decrease cgas ) OR ( significant bias decrease ))', query time: 0.37s Refine Results
  1. 161
    Inclusion of literature flowchart.

    Inclusion of literature flowchart. by Xiaodong Jia (783460)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  2. 162
    Effect of biologics on low density lipoprotein (LDL).

    Effect of biologics on low density lipoprotein (LDL). by Xiaodong Jia (783460)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  3. 163
    Effect of biological agents on total cholesterol outcomes forest results.

    Effect of biological agents on total cholesterol outcomes forest results. by Xiaodong Jia (783460)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  4. 164
    Sensitivity analysis.

    Sensitivity analysis. by Xiaodong Jia (783460)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  5. 165
    Effect of biologics on triglyceride outcomes of RA forest results.

    Effect of biologics on triglyceride outcomes of RA forest results. by Xiaodong Jia (783460)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  6. 166
    Forest plot of the effect of biologic therapy versus conventional therapy on low-density lipoprotein levels stratified by different drug treatments.

    Forest plot of the effect of biologic therapy versus conventional therapy on low-density lipoprotein levels stratified by different drug treatments. by Xiaodong Jia (783460)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  7. 167
    Forest plot of the effect of biologic therapy versus conventional therapy on total cholesterol levels stratified by different drug treatments.

    Forest plot of the effect of biologic therapy versus conventional therapy on total cholesterol levels stratified by different drug treatments. by Xiaodong Jia (783460)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  8. 168
    Basic characteristics of research.

    Basic characteristics of research. by Xiaodong Jia (783460)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  9. 169
    Forest plot of the effect of biologic therapy versus conventional therapy on triglyceride levels stratified by treatment duration.

    Forest plot of the effect of biologic therapy versus conventional therapy on triglyceride levels stratified by treatment duration. by Xiaodong Jia (783460)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  10. 170
    Forest plot of the effect of biologic therapy versus conventional therapy on triglyceride levels stratified by different drug treatments.

    Forest plot of the effect of biologic therapy versus conventional therapy on triglyceride levels stratified by different drug treatments. by Xiaodong Jia (783460)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  11. 171
    Image_2_Biodegradable nanoparticles induce cGAS/STING-dependent reprogramming of myeloid cells to promote tumor immunotherapy.tif

    Image_2_Biodegradable nanoparticles induce cGAS/STING-dependent reprogramming of myeloid cells to promote tumor immunotherapy.tif by Joseph R. Podojil (12050717)

    Published 2022
    “…The present studies describe a novel use for ONP-302, employing an altered dosing scheme to reprogram myeloid cells resulting in significant enhancement of tumor immunity. ONP-302 infusion decreased tumor growth via the activation of the cGAS/STING pathway within myeloid cells, and subsequently increased NK cell activation via an IL-15-dependent mechanism. …”
    Save to List
    Saved in:
  12. 172
    Table_7_Biodegradable nanoparticles induce cGAS/STING-dependent reprogramming of myeloid cells to promote tumor immunotherapy.pdf

    Table_7_Biodegradable nanoparticles induce cGAS/STING-dependent reprogramming of myeloid cells to promote tumor immunotherapy.pdf by Joseph R. Podojil (12050717)

    Published 2022
    “…The present studies describe a novel use for ONP-302, employing an altered dosing scheme to reprogram myeloid cells resulting in significant enhancement of tumor immunity. ONP-302 infusion decreased tumor growth via the activation of the cGAS/STING pathway within myeloid cells, and subsequently increased NK cell activation via an IL-15-dependent mechanism. …”
    Save to List
    Saved in:
  13. 173
    Table_2_Biodegradable nanoparticles induce cGAS/STING-dependent reprogramming of myeloid cells to promote tumor immunotherapy.pdf

    Table_2_Biodegradable nanoparticles induce cGAS/STING-dependent reprogramming of myeloid cells to promote tumor immunotherapy.pdf by Joseph R. Podojil (12050717)

    Published 2022
    “…The present studies describe a novel use for ONP-302, employing an altered dosing scheme to reprogram myeloid cells resulting in significant enhancement of tumor immunity. ONP-302 infusion decreased tumor growth via the activation of the cGAS/STING pathway within myeloid cells, and subsequently increased NK cell activation via an IL-15-dependent mechanism. …”
    Save to List
    Saved in:
  14. 174
    Table_8_Biodegradable nanoparticles induce cGAS/STING-dependent reprogramming of myeloid cells to promote tumor immunotherapy.pdf

    Table_8_Biodegradable nanoparticles induce cGAS/STING-dependent reprogramming of myeloid cells to promote tumor immunotherapy.pdf by Joseph R. Podojil (12050717)

    Published 2022
    “…The present studies describe a novel use for ONP-302, employing an altered dosing scheme to reprogram myeloid cells resulting in significant enhancement of tumor immunity. ONP-302 infusion decreased tumor growth via the activation of the cGAS/STING pathway within myeloid cells, and subsequently increased NK cell activation via an IL-15-dependent mechanism. …”
    Save to List
    Saved in:
  15. 175
    Image_1_Biodegradable nanoparticles induce cGAS/STING-dependent reprogramming of myeloid cells to promote tumor immunotherapy.tif

    Image_1_Biodegradable nanoparticles induce cGAS/STING-dependent reprogramming of myeloid cells to promote tumor immunotherapy.tif by Joseph R. Podojil (12050717)

    Published 2022
    “…The present studies describe a novel use for ONP-302, employing an altered dosing scheme to reprogram myeloid cells resulting in significant enhancement of tumor immunity. ONP-302 infusion decreased tumor growth via the activation of the cGAS/STING pathway within myeloid cells, and subsequently increased NK cell activation via an IL-15-dependent mechanism. …”
    Save to List
    Saved in:
  16. 176
    Image_4_Biodegradable nanoparticles induce cGAS/STING-dependent reprogramming of myeloid cells to promote tumor immunotherapy.tif

    Image_4_Biodegradable nanoparticles induce cGAS/STING-dependent reprogramming of myeloid cells to promote tumor immunotherapy.tif by Joseph R. Podojil (12050717)

    Published 2022
    “…The present studies describe a novel use for ONP-302, employing an altered dosing scheme to reprogram myeloid cells resulting in significant enhancement of tumor immunity. ONP-302 infusion decreased tumor growth via the activation of the cGAS/STING pathway within myeloid cells, and subsequently increased NK cell activation via an IL-15-dependent mechanism. …”
    Save to List
    Saved in:
  17. 177
    Image_5_Biodegradable nanoparticles induce cGAS/STING-dependent reprogramming of myeloid cells to promote tumor immunotherapy.tif

    Image_5_Biodegradable nanoparticles induce cGAS/STING-dependent reprogramming of myeloid cells to promote tumor immunotherapy.tif by Joseph R. Podojil (12050717)

    Published 2022
    “…The present studies describe a novel use for ONP-302, employing an altered dosing scheme to reprogram myeloid cells resulting in significant enhancement of tumor immunity. ONP-302 infusion decreased tumor growth via the activation of the cGAS/STING pathway within myeloid cells, and subsequently increased NK cell activation via an IL-15-dependent mechanism. …”
    Save to List
    Saved in:
  18. 178
    Table_3_Biodegradable nanoparticles induce cGAS/STING-dependent reprogramming of myeloid cells to promote tumor immunotherapy.pdf

    Table_3_Biodegradable nanoparticles induce cGAS/STING-dependent reprogramming of myeloid cells to promote tumor immunotherapy.pdf by Joseph R. Podojil (12050717)

    Published 2022
    “…The present studies describe a novel use for ONP-302, employing an altered dosing scheme to reprogram myeloid cells resulting in significant enhancement of tumor immunity. ONP-302 infusion decreased tumor growth via the activation of the cGAS/STING pathway within myeloid cells, and subsequently increased NK cell activation via an IL-15-dependent mechanism. …”
    Save to List
    Saved in:
  19. 179
    Table_5_Biodegradable nanoparticles induce cGAS/STING-dependent reprogramming of myeloid cells to promote tumor immunotherapy.pdf

    Table_5_Biodegradable nanoparticles induce cGAS/STING-dependent reprogramming of myeloid cells to promote tumor immunotherapy.pdf by Joseph R. Podojil (12050717)

    Published 2022
    “…The present studies describe a novel use for ONP-302, employing an altered dosing scheme to reprogram myeloid cells resulting in significant enhancement of tumor immunity. ONP-302 infusion decreased tumor growth via the activation of the cGAS/STING pathway within myeloid cells, and subsequently increased NK cell activation via an IL-15-dependent mechanism. …”
    Save to List
    Saved in:
  20. 180
    Table_4_Biodegradable nanoparticles induce cGAS/STING-dependent reprogramming of myeloid cells to promote tumor immunotherapy.pdf

    Table_4_Biodegradable nanoparticles induce cGAS/STING-dependent reprogramming of myeloid cells to promote tumor immunotherapy.pdf by Joseph R. Podojil (12050717)

    Published 2022
    “…The present studies describe a novel use for ONP-302, employing an altered dosing scheme to reprogram myeloid cells resulting in significant enhancement of tumor immunity. ONP-302 infusion decreased tumor growth via the activation of the cGAS/STING pathway within myeloid cells, and subsequently increased NK cell activation via an IL-15-dependent mechanism. …”
    Save to List
    Saved in:

Search Tools: